Rib-X Pharmaceuticals, Inc. announced today that Mary Szela has been appointed to its Board of Directors as its Chair. Ms. Szela brings her 25-year career as an accomplished pharmaceutical executive to this leadership role. “Mary Szela brings a wealth of talent and expertise to our team and is an outstanding choice to lead our Board of Directors,” said Mark Leuchtenberger, Chief Executive Officer of Rib-X.
